## Correct Answer: D. Hemochromatosis Hemochromatosis presents with the classic triad of hepatomegaly, hyperpigmentation (dark tan skin from melanin deposition and iron-induced oxidative damage), and cirrhosis. The microscopy slide (though not shown here) would reveal **Prussian blue-positive iron deposits** in hepatocytes, particularly in periportal zones, which is pathognomonic for iron overload. In India, hereditary hemochromatosis (HFE gene mutation) is less common than secondary hemochromatosis from chronic transfusions (thalassemia major, sickle cell disease) or cirrhosis from other causes, but the clinical presentation remains identical. The dark tan hyperpigmentation is due to iron deposition in the skin and melanin stimulation by oxidative stress. Iron accumulation causes hepatocyte necrosis, fibrosis, and eventually cirrhosis with increased risk of hepatocellular carcinoma. The diagnosis is confirmed by elevated serum ferritin, elevated transferrin saturation (>45%), and Prussian blue staining on liver biopsy showing iron in hepatocytes. Early recognition and phlebotomy or chelation therapy can prevent cirrhosis and its complications. ## Why the other options are wrong **A. Autoimmune hepatitis** — Autoimmune hepatitis presents with jaundice, fatigue, and elevated transaminases, but does NOT cause hyperpigmentation or the characteristic iron deposition on Prussian blue staining. Histology shows lymphocytic infiltration and interface hepatitis, not iron deposits. The clinical triad of hepatomegaly + dark tan + iron-laden hepatocytes is incompatible with autoimmune hepatitis. **B. Alpha-1 antitrypsin deficiency** — Alpha-1 antitrypsin deficiency causes progressive cirrhosis and emphysema, but hyperpigmentation is NOT a feature. Liver histology shows **PAS-positive, diastase-resistant globules** in hepatocytes (not iron), which are pathognomonic for AAT deficiency. The absence of iron deposits and the presence of dark tan skin make this diagnosis unlikely. **C. Wilson's disease** — Wilson's disease presents with hepatitis, neuropsychiatric symptoms, and **Kayser-Fleischer rings** (not hyperpigmentation). Histology shows copper deposition (confirmed by orcein or rhodanine staining), not iron. While both cause cirrhosis, the dark tan skin and Prussian blue-positive iron deposits are diagnostic for hemochromatosis, not Wilson's disease. ## High-Yield Facts - **Prussian blue staining** is the gold standard for detecting iron deposits in hepatocytes; positive staining in periportal hepatocytes is diagnostic for hemochromatosis. - **Hyperpigmentation (dark tan)** in hemochromatosis results from iron deposition in skin and melanin stimulation; often described as 'bronze diabetes' when diabetes coexists. - **Serum ferritin >300 ng/mL** and **transferrin saturation >45%** are screening markers; liver biopsy with iron quantification confirms diagnosis. - **Secondary hemochromatosis** from chronic transfusions (thalassemia major, sickle cell disease) is more common in India than hereditary HFE-related hemochromatosis. - **Cirrhosis and hepatocellular carcinoma** develop within 10–20 years if untreated; phlebotomy or chelation therapy (desferrioxamine, deferasirox) halts progression if started early. ## Mnemonics **Iron Overload Triad** **HEM** = **H**epatomegaly, **E**ndocrine dysfunction (diabetes), **M**elanin hyperpigmentation (dark tan). This triad is classic for hemochromatosis and distinguishes it from other chronic liver diseases. **Prussian Blue = Iron** When you see **Prussian blue-positive deposits** on liver biopsy, think **hemochromatosis**. This stain is specific for ferric iron and is the diagnostic gold standard. Other stains (orcein = copper in Wilson's, PAS = AAT globules) point to different diagnoses. ## NBE Trap NBE may pair hepatomegaly + cirrhosis with Wilson's disease (another metabolic liver disease) to trap students who confuse metabolic causes of cirrhosis. The discriminator is hyperpigmentation + Prussian blue iron deposits, which are unique to hemochromatosis. ## Clinical Pearl In Indian clinical practice, secondary hemochromatosis from chronic transfusions in thalassemia major is more prevalent than hereditary hemochromatosis. A 55-year-old with hepatomegaly + dark skin should prompt iron studies and Prussian blue staining; early phlebotomy can prevent cirrhosis and HCC, which are leading causes of death in untreated hemochromatosis patients. _Reference: Robbins and Cotran Pathologic Basis of Disease, Ch. 18 (Liver and Biliary System); Harrison's Principles of Internal Medicine, Ch. 355 (Hemochromatosis)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.